Patents & exclusivity
When will a generic be available?
Popular brand-name drugs with no generic yet, and the date their last listed patent runs out. Generics often launch around then - though court rulings and settlements can move the date.
| Brand | Pharmacies pay | Last patent |
|---|---|---|
| Striverdi | - | Jan 19, 2027 |
| Nevanac | $315 | Jan 31, 2027 |
| Duavee | $194 | Mar 10, 2027 |
| Incruse | $10.27 | Dec 18, 2027 |
| Alvesco | - | Feb 1, 2028 |
| Omnaris | - | Feb 1, 2028 |
| Cresemba | $3,421 | Mar 14, 2028 |
| Edarbi | $248 | Mar 26, 2028 |
| Savaysa | $464 | Mar 28, 2028 |
| Osphena | $245 | Jul 9, 2028 |
| Tudorza | $7,738 | Mar 13, 2029 |
| Rukobia | $4,698 | Jul 13, 2029 |
| Invokamet | $286 | Aug 26, 2029 |
| Invokana | $573 | Aug 26, 2029 |
| Vraylar | $1,523 | Mar 17, 2030 |
| Airsupra | - | May 28, 2030 |
| Triumeq | $3,902 | Jun 8, 2030 |
| Tivicay | $2,329 | Jun 8, 2030 |
| Ella | $1,112 | Jun 12, 2030 |
| Eucrisa | $642 | Jul 20, 2030 |
| Voquezna | $672 | Aug 11, 2030 |
| Exxua | $1,689 | Sep 2, 2030 |
| Inpefa | $611 | Oct 7, 2030 |
| Stiolto | - | Oct 16, 2030 |
| Simbrinza | $208 | Oct 30, 2030 |
| Anoro | $56.23 | Nov 29, 2030 |
| Sivextro | $14,274 | Dec 31, 2030 |
| Dovato | $3,157 | Jan 24, 2031 |
| Bevespi | - | Mar 17, 2031 |
| Intrarosa | $307 | Mar 19, 2031 |
| Xadago | $1,090 | Mar 21, 2031 |
| Breo | $74.91 | Apr 11, 2031 |
| Trelegy | $155 | Apr 11, 2031 |
| Multaq | $396 | Jun 30, 2031 |
| Edarbyclor | $255 | Jul 1, 2031 |
| Eliquis | $165 | Aug 24, 2031 |
| Winlevi | $600 | Aug 26, 2031 |
| Qnasl | - | Oct 21, 2031 |
| Segluromet | $171 | Dec 19, 2031 |
| Steglatro | $343 | Dec 19, 2031 |
| Steglujan | $528 | Dec 19, 2031 |
| Fanapt | $915 | Dec 28, 2031 |
| Neupro | $20,280 | Mar 1, 2032 |
| Ilevro | $363 | Mar 31, 2032 |
| Movantik | $438 | Apr 2, 2032 |
| Fetzima | $17.61 | May 23, 2032 |
| Pifeltro | $1,824 | Aug 30, 2032 |
| Trintellix | $516 | Sep 21, 2032 |
| Prezcobix | $2,400 | Oct 6, 2032 |
| Evotaz | $1,561 | Oct 6, 2032 |
| Verquvo | $682 | Nov 26, 2032 |
| Olumiant | $2,777 | Nov 30, 2032 |
| Ongentys | $740 | Dec 12, 2032 |
| Baxfendy | $865 | Feb 4, 2033 |
| Odefsey | $3,914 | Feb 15, 2033 |
| Vemlidy | $1,560 | Feb 15, 2033 |
| Viberzi | $843 | Mar 14, 2033 |
| Phexxi | $364 | Mar 15, 2033 |
| Phexx | $364 | Mar 15, 2033 |
| Genvoya | $4,301 | Apr 6, 2033 |
| Stribild | $4,504 | Apr 6, 2033 |
| Rexulti | $1,484 | Apr 12, 2033 |
| Symproic | $488 | May 13, 2033 |
| Belsomra | $456 | May 29, 2033 |
| Aklief | $734 | May 30, 2033 |
| Veltassa | $136 | Oct 8, 2033 |
| Natroba | $264 | Nov 25, 2033 |
| Linzess | $270 | Feb 16, 2034 |
| Rocklatan | $348 | Mar 14, 2034 |
| Rhopressa | $329 | Mar 14, 2034 |
| Rayaldee | $1,236 | Mar 14, 2034 |
| Veozah | $557 | Mar 28, 2034 |
| Zavzpret | $1,140 | Jun 26, 2034 |
| Epclusa | $25,950 | Jul 30, 2034 |
| Otezla | $98.76 | Nov 29, 2034 |
| Quviviq | $501 | Dec 2, 2034 |
| Jardiance | $336 | Dec 11, 2034 |
| Synjardy | $168 | Dec 11, 2034 |
| Zegalogue | $296 | Mar 22, 2035 |
| Qelbree | $382 | Apr 2, 2035 |
| Velphoro | $513 | May 26, 2035 |
| Zelsuvmi | - | Jul 10, 2035 |
| Kerendia | $685 | Jul 29, 2035 |
| Lokelma | $312 | Oct 14, 2035 |
| Dayvigo | $347 | Oct 21, 2035 |
| Accrufer | $303 | Oct 23, 2035 |
| Cibinqo | $5,913 | Jan 14, 2036 |
| Velsipity | $6,542 | Jun 21, 2036 |
| Descovy | $2,246 | Jun 29, 2036 |
| Kisqali | $14,572 | Oct 14, 2036 |
| Biktarvy | $4,099 | Nov 8, 2036 |
| Delstrigo | $2,792 | Nov 29, 2036 |
| Mavyret | $4,587 | Dec 24, 2036 |
| Miebo | - | Jun 21, 2037 |
| Sutab | $202 | Aug 4, 2037 |
| Foundayo | $625 | Sep 26, 2037 |
| Jentadueto | $253 | Dec 8, 2037 |
| Trijardy | $169 | Dec 8, 2037 |
| Glyxambi | $336 | Dec 8, 2037 |
| Tradjenta | $504 | Dec 8, 2037 |
| Azstarys | $432 | Dec 9, 2037 |
| Clenpiq | $181 | Jan 27, 2038 |
| Rinvoq | $6,881 | Mar 9, 2038 |
| Symtuza | $4,586 | Jul 19, 2038 |
| Juluca | $3,657 | Sep 5, 2038 |
| Breztri | - | Oct 5, 2038 |
| Ozempic | $995 | Feb 1, 2039 |
| Rybelsus | $996 | Feb 1, 2039 |
| Nuplazid | $5,115 | Feb 27, 2039 |
| Nurtec | $3,860 | Mar 25, 2039 |
| Aristada | $1,611 | Apr 6, 2039 |
| Xcopri | $7.82 | Jun 16, 2039 |
| Annovera | $69,409 | Jun 21, 2039 |
| Zepbound | $483 | Jul 22, 2039 |
| Xofluza | $4,857 | Oct 9, 2039 |
| Yupelri | $1,569 | Oct 23, 2039 |
| Cobenfy | $30.12 | Oct 29, 2039 |
| Vtama | $1,515 | Dec 18, 2039 |
| Spravato | $854 | Feb 18, 2040 |
| Nexletol | $414 | Jun 19, 2040 |
| Nexlizet | $414 | Jun 19, 2040 |
| Reyvow | $2,661 | Jul 6, 2040 |
| Ingrezza | $8,118 | Aug 10, 2040 |
| Orilissa | $658 | Aug 27, 2040 |
| Journavx | $462 | Dec 4, 2040 |
| Caplyta | $1,716 | Dec 10, 2040 |
| Wegovy | $871 | Feb 17, 2041 |
| Opzelura | $2,040 | May 5, 2041 |
| Twyneo | $950 | May 23, 2041 |
| Austedo | $2,494 | Jun 10, 2041 |
| Qvar | - | Aug 19, 2041 |
| Lybalvi | $1,649 | Nov 12, 2041 |
| Icotyde | $8,401 | Nov 19, 2041 |
| Solosec | $281 | Dec 11, 2041 |
| Ubrelvy | $3,266 | Dec 22, 2041 |
| Mounjaro | $1,077 | Dec 30, 2041 |
| Talicia | $146 | May 27, 2042 |
| Gemtesa | $494 | Jul 6, 2042 |
| Cardamyst | $3,159 | Jul 15, 2042 |
| Myfembree | $1,357 | Nov 5, 2042 |
| Ibsrela | $976 | Nov 26, 2042 |
| Blujepa | $2,738 | Dec 13, 2042 |
| Tryptyr | $844 | Dec 16, 2042 |
| Sunosi | $940 | Dec 30, 2042 |
| Qulipta | $1,150 | Feb 27, 2043 |
| Auvelity | $19.82 | Nov 28, 2043 |
| Rhapsido | $2,175 | Dec 9, 2043 |
| Ryaltris | - | Nov 21, 2044 |
| Symbravo | $3,679 | Mar 10, 2045 |
| Lynkuet | $299 | May 14, 2045 |
Dates are the latest patent and exclusivity the maker lists for the brand's application. A generic can launch earlier (a patent challenge) or later (other patents, litigation, settlements).
Get drug price alerts
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.